| 名稱 | CYP2D6*2_p.S486T Reference Standard |
| 型號 | CBPA0002 |
| 報價 |  |
| 特點 | CYP2D6*2_p.S486T Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- IHC第三方質(zhì)控品——病理質(zhì)控基石，精準(zhǔn)診斷起點
- 重磅！科學(xué)家成功利用免疫細(xì)胞運輸抗癌藥物至腫瘤靶點
- 百時美免疫組合治療非小細(xì)胞肺癌展現(xiàn)驚人療效
- 【盤點】癌癥免疫檢查點療法的現(xiàn)狀與展望
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 用藥指導(dǎo) > CBPA0002CYP2D6*2_p.S486T Reference Standard
- 詳細(xì)內(nèi)容
| CBPA0002 | |
| Format | Genomic DNA |
| Description | CYP2D6, cytochrome P450 family 2 subfamily D member 6, is a member of the cytochrome P450 family of monooxygenases that catalyzes drug metabolism (PMID: 28480783). CYP2D6 variants have been associated with risks of various cancers (PMID: 22994728, PMID: 16550168) and may alter the metabolism of tamoxifen in breast cancer patients. |
| Technical Data | |
| Gene | CYP2D6 |
| AA Change | p.S486T |
| DNA Change | NM_000106.6_c.1457G>C |
| Chr position (GRCh38) | NC_000022.11_g.42126611C>G |
| Allelic Frequency | 50% |
| Zygosity | Heterozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
